Drug – bio-affecting and body treating compositions – In vivo diagnostic or in vivo test agent which contains an...
Patent
1995-06-07
1998-12-08
Minnifield, Nita
Drug, bio-affecting and body treating compositions
In vivo diagnostic or in vivo test agent which contains an...
4241841, 4241461, 514825, 514 12, 435194, 436506, 436507, 436508, 436509, 536 11, A61K 3900, A61K 3938, A61K 39395, A61K 3800
Patent
active
058465324
ABSTRACT:
A method and composition are provided for treatment of disorders involving immunological dysfunction. The invention comprises the administration of a low level of ribonucleotide polymerase protein or a derivative thereof to a human or animal with an immune dysfunction disorder.
REFERENCES:
patent: 4294818 (1981-10-01), McMichael et al.
patent: 4582793 (1986-04-01), Jacob
patent: 4751181 (1988-06-01), Keene
patent: 5077211 (1991-12-01), Yarosh
patent: 5116615 (1992-05-01), Gokeen et al.
Kotzin, B.L. et al., "Preferential T-cell Receptor .beta.-chain Variable Gene Use in Myelin Basic Protein-reactive T-cell Clones from Patients with Multiple Sclerosis," PNAS, vol. 88, pp. 9161-9165 (Oct. 1991).
McNeilage, L.J. et al., "Review: Autoantibodies Reactive with Small Ribonucleoprotein Antigens: A Convergence of Molecular Biology Clinical Immunology," J. Clin. Lab. Immunol., vol. 15, pp. 1-17, (1984).
Stetler et al., "Antibodies to Distinct Polypeptides of RNA Polymerase I in Sera From Patients with Rheumatic Autoimmune Disease," PNAS, vol. 79, pp. 7499-7503 (Dec. 1982).
Stetler et al., "Immunization of Rabbits with Purified RNA Polymerase I Induces A Distinct Population of Antibodies Against Nucleic Acids As Well As Anti-RNA Polymerase I Antibodies Both Characteristic of Systematic Lupus Erythematosus," PNAS, vol. 82, pp. 6797-6801 (Oct. 1985).
Reimer et al., "Atuoantibody to RNA Polymerase I in Scleroderma Sera," J. Clin. Invest., vol. 79, pp. 65-72 (Jan. 1987).
Biochemical and Organic Compounds for Research and Diagnostic Clinical Reagents Catalog, Sigma Chemical Co., p. 1266 (1988).
Fox, 1994, Bio/Technology 12:128.
Haynes. 1993 Science 260: 1279-86.
Sandstrom et al. 1987. Drugs 34: 372-390.
Langer 1990 Science 249: 1527-33.
Minnifield Nita
Molecular Rx, Inc.
LandOfFree
Method and composition for the treatment of disorders involving does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method and composition for the treatment of disorders involving , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and composition for the treatment of disorders involving will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-174532